LTRN
$15.43
Lantern Pharma
$.13
.85%
LTRN
Earnings Whisper ®
N/A
4th Quarter December 2020
Consensus:  ($0.41)
Revenue:  $0.00 Mil
Thursday
Jan 28
After the close
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when LTRN reports earnings?
Beat
Meet
Miss

Where is LTRN's stock price going from here?
Up
Flat
Down
Stock chart of LTRN
Analysts
Summary of analysts' recommendations for LTRN
Score
Grade
Pivots
Resistance
-
-
-

-

Support
-
-
-
Tweet
Growth
Description
Lantern Pharma Inc.is a biotechnology company. It develops medicines for multi-drug treatment resistance cancers focusing on prostate and ovarian cancers. The company's drug candidate consist LP-100, LP-300 and LP-184 which are in clinical stage. Lantern Pharma Inc.is based in Dallas, Texas.